REAL-WORLD COST PER PERSISTING PATIENT: COMPARING PSORIASIS PATIENTS INITIATED ON APREMILAST OR BIOLOGIC THERAPIES

被引：0
|
作者：
Feldman, S. R. [1 ]
Kuznik, A. [2 ,3 ]
Clancy, Z. [2 ]
机构：
[1] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
[2] Celgene Corp, Warren, NJ USA
[3] Regeneron Pharmaceut, Warren, NJ USA
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.512
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS21
引用
收藏
页码：A125 / A125
页数：1
相关论文
共 50 条
  • [1] TREATMENT PERSISTENCE IN PSORIASIS PATIENTS INITIATED ON APREMILAST, ORAL SYSTEMICS, OR BIOLOGIC THERAPIES
    Feldman, S. R.
    Kaura, S.
    Li, S.
    Tencer, T.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A805 - A805
  • [2] HEALTH CARE COSTS IN PSORIASIS PATIENTS NEWLY INITIATED ON APREMILAST OR BIOLOGIC THERAPIES
    Feldman, S.
    Kuznik, A.
    Clancy, Z.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A128 - A128
  • [3] Real-world treatment patterns of adults with psoriasis initiated on apremilast or biologics
    Wu, Jashin J.
    Wang, Ann
    Jobson, Greeta
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB101 - AB101
  • [4] Real-world use of apremilast for patients with psoriasis in Japan
    Kishimoto, Megumi
    Komine, Mayumi
    Hioki, Tomoyuki
    Kamiya, Koji
    Sugai, Junichi
    Ohtsuki, Mamitaro
    [J]. JOURNAL OF DERMATOLOGY, 2018, 45 (11): : 1345 - 1348
  • [5] Real-world US healthcare costs of psoriasis for biologic-naive patients initiating apremilast or biologics
    Feldman, Steven R.
    Pelletier, Corey L.
    Wilson, Kathleen L.
    Mehta, Rina K.
    Brouillette, Matthew A.
    Smith, David
    Bonafede, Machaon M.
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (01) : 45 - 54
  • [6] Real-World Effectiveness and Safety of Apremilast in Older Patients with Psoriasis
    Phan, Celine
    Beneton, Nathalie
    Delaunay, Juliette
    Reguiai, Ziad
    Boulard, Claire
    Fougerousse, Anne-Claire
    Cinotti, Elisa
    Romanelli, Marco
    Mery-Bossard, Laure
    Thomas-Beaulieu, Domitille
    Parier, Josiane
    Maccari, Francois
    Chaby, Guillaume
    Bastien, Marie
    Begon, Edouard
    Samimi, Mahtab
    Prignano, Francesca
    Beauchet, Alain
    Mahe, Emmanuel
    [J]. DRUGS & AGING, 2020, 37 (09) : 657 - 663
  • [7] Real-World Effectiveness and Safety of Apremilast in Older Patients with Psoriasis
    Céline Phan
    Nathalie Beneton
    Juliette Delaunay
    Ziad Reguiai
    Claire Boulard
    Anne-Claire Fougerousse
    Elisa Cinotti
    Marco Romanelli
    Laure Mery-Bossard
    Domitille Thomas-Beaulieu
    Josiane Parier
    François Maccari
    Guillaume Chaby
    Marie Bastien
    Edouard Begon
    Mahtab Samimi
    Francesca Prignano
    Alain Beauchet
    Emmanuel Mahé
    [J]. Drugs & Aging, 2020, 37 : 657 - 663
  • [8] Real-world experiences of apremilast in clinics for Japanese patients with psoriasis
    Saruwatari, Hiroshi
    [J]. JOURNAL OF DERMATOLOGY, 2019, 46 (12): : 1166 - 1169
  • [9] Real-World Experience With Apremilast in Treating Psoriasis
    Mayba, Julia N.
    Gooderham, Melinda J.
    [J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2017, 21 (02) : 145 - 151
  • [10] Apremilast in psoriasis - a prospective real-world study
    Vujic, I.
    Herman, R.
    Sanlorenzo, M.
    Posch, C.
    Monshi, B.
    Rappersberger, K.
    Richter, L.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S195 - S195
12345